Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987415 · ClinicalTrials.gov registry record · Phase 2
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 253
- Enrollment target
NCT00987415 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 253 participants.
The verdict
NCT00987415, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 253 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether allopurinol is effective in relieving symptoms of patients with heart failure and high blood uric acid levels.
Interventions
- DRUG allopurinol
- DRUG sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2010-05 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00987415
The ClinicalTrials.gov registry entry for NCT00987415 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which allopurinol is the first listed.
NCT00987415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00987415 about?
NCT00987415 is a clinical study titled "Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels". The purpose of this study is to determine whether allopurinol is effective in relieving symptoms of patients with heart failure and high blood uric acid levels.
What is the current status of trial NCT00987415?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 253 participants. The study started on 2010-05. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00987415?
The interventions under investigation include: allopurinol (DRUG), sugar pill (DRUG).
Who is sponsoring clinical trial NCT00987415?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.